JF
VIVO

Jump Financial’s Meridian Bioscience Inc VIVO Stock Holding History

Jump Financial’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-17,000
Closed -$347K – 2048
2021
Q4 		$347K Buy
+17,000
New +$326K 0.02% 816
2021
Q1 		– Sell
-14,496
Closed -$271K – 1402
2020
Q4 		$271K Buy
+14,496
New +$271K 0.05% 636

Other funds holding VIVO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VLKIM
Van Lanschot Kempen Investment Management Amsterdam, Netherlands $11.4B AUM 16.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's VIVO Position: Q1 2022 in Review

Jump Financial sold out of Meridian Bioscience Inc (VIVO) in Q1 2022, closing a stake of 17,000 shares — an estimated $347K sold.

Jump Financial first reported a position in VIVO in Q4 2020 and held it in 2 quarters. The position peaked at $347K in Q4 2021. 210 funds tracked by Wall St. Rank hold VIVO as of Q1 2022.

  • Jump Financial reported no remaining Meridian Bioscience Inc position as of Q1 2022 after selling out during the quarter.
  • Jump Financial sold 17,000 Meridian Bioscience Inc shares in Q1 2022, an estimated $347K.
  • Jump Financial first reported a position in Meridian Bioscience Inc in Q4 2020 and held it in 2 quarters.
  • Jump Financial's Meridian Bioscience Inc position peaked at $347K in Q4 2021.
  • 210 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2022.

Based on Jump Financial's 13F filing for Q1 2022, filed 12 May 2022.